The burden of infection with herpes simplex virus type 1 and type 2: Seroprevalence study in Estonia

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 10, 2004, Pages 727-732

  Uusküla, Anneli ^a   Nygard Kibur, Mari ^b,c   Cowan, Frances M ^d   Mayaud, Philippe ^e   French, Rebecca S ^d   Robinson, Jamie N R ^f   Brown, David W G ^g  

^a UNIVERSITY OF TARTU   (Estonia)

^b Cancer Registry of Norway   (Norway)

^c Estonian Inst of Exp/Clin Med   (Estonia)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^g GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; EASTERN EUROPE; EPIDEMIC; ESTONIA; FEMALE; GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; POPULATION RESEARCH; PRENATAL CARE; SEROPREVALENCE; SEX DIFFERENCE; SEXUALLY TRANSMITTED DISEASE;

EID: 7944230363     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410020992a     Document Type: Article

References (48)

1. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex infection in the world. Scand J Infect Dis 1990; 69(Suppl): 19-36.
2. Mindel A. Genital herpes: how much of a public-health problem? Lancet 1998; 352(Suppl 3): 16-8.
3. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337: 1105-11.
4. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 1 and 2: a global review. J Infect Dis 2002; 186(Suppl 1): S3-28.
5. Janier M, Lassau F, Bloch J, Spindler E, Morel P, Gerard P. Seroprevalence of herpes simplex virus type 2 antibodies in a STD clinic in Paris. Int J STD & AIDS 1999; 10: 522-6.
6. Vyse AJ, Gay NJ, Slomka MJ, Gopal R, Gibbs T, Morgan-Capner P, Brown DW. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000; 76: 183-7.
7. Wutzler P, Doerr HW, Farber I, Eichhorn U, Helbig B, Sauerbrei A. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations: relevance for the incidence of genital herpes. J Med Virol 2000; 61: 201-7.
8. Kibur M, Koskela P, Dillner J, Leinikki P, Saikku P, Lehtinen M, et al. Seropositivity to multiple STIs is not common. Sex Transm Dis 2000; 27: 425-30.
9. Cusinis M, Cusan M, Parolini C, Scioccati L, Decleva I, Mengoli C. Seroprevalence of herpes simplex virus type 2 infection among attendees of a sexually transmitted clinic in Italy. Sex Transm Dis 2000; 27: 292-5.
10. Lowhagen GB, Tunback P, Andersson K, Bergström T, Johannison G. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm Infect 2000; 76: 179-82.
11. Cowan F, Johnson AM, Ashley R, Corey L, Mindel A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. Br Med J 1994; 309: 1325-9.
12. van de Laar MJ, Termorshuizen F, Slomka MJ, van Doornum GJ, Ossewaarde JM, Brown DW, et al. Prevalence and correlates of herpes simplex virus type 2 infection: evaluation of behavioural risk factors. Int J Epidemiol 1998; 27: 127-34.
13. Auvert B, Ballard R, Campbell C, Carael M, Carton M, Fehler G, et al. HIV infection among youth in a South African mining town is associated with herpes simplex virus type 2 seropositivity and sexual behaviour. AIDS 2001; 15: 885-98.
14. Weiss HA, Buve A, Robinson NJ, Van Dyck E, Kahindo M, Anagonou S, et al. The epidemiology of HSV-2 infection and its association with HIV infection in 4 urban African populations. AIDS 2001; 15(Suppl 4): S97-108.
15. Obasi A, Mosha F, Quigley M, Sekirassa Z, Gibbs T, Munguti K, et al. Antibody to herpes simplex virus type 2 as a marker of sexual risk behaviour in rural Tanzania. J Infect Dis 1999; 179: 16-24.
16. WHO. Herpes simplex virus type 2. Programmatic and research priorities in developing countries. Report of a WHO/UNAIDS/LSHTM workshop (London 14-16 February 2001). Geneva: WHO/HIV_AIDS/2001.05 and UNAIDS/01.89E.
17. Thomson C. Genital herpes simplex typing in genitourinary medicine: 1995-1999. Int J STD & AIDS 2000; 11: 501-2.
18. Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 2000; 181: 1454-7.
19. Nilsen A, Myrmel H. Changing trends in genital herpes simplex virus infection in Bergen, Norway. Acta Obstet Gynecol Scand 2000; 79: 693-6.
20. Waugh MA. Task force for the urgent response to the epidemics of sexually transmitted diseases in Eastern Europe and central Asia. Int J STD & AIDS 1999; 10: 60-2.
21. Riedner G, Dehne KL, Gromyko A. Recent declines in reported syphilis rates in Eastern Europe and central Asia: are the epidemics over? Sex Transm Infect 2000; 76: 363-5.
22. Uusküla A, Silm H, Vessin T. Sexually transmitted diseases in Estonia: past and present. Int J STD & AIDS 1997; 8: 446-50.
23. Uusküla A, Kalikova N, Zilmer K, Tammai L, DeHovitz J. The role of injecting drug use in the emergence of HIV in Estonia. International Journal of Infectious Diseases 2002; 6: 23-7.
24. Lowndes CM, Alary M, Platt L. Injection drug use, commercial sex work, and the HIV/STI epidemic in the Russian Federation. Sex Transm Dis 2003; 30: 46-8.
25. Cowan FM, French RS, Mayaud P, Gopal R, Robinson NJ, de Oliveira SA, et al. Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sex Transm Infect 2003; 79: 286-90.
26. http://www.tervisekaitse.ee/tkuus.php?msgid=43 17.06.2003.
27. Statistical Office of Estonia, 2002. Population de facto and usually resident population, location of the population, population sex and age structure.
28. Prince HE, Ernst CE, Hogrefe WR. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies. J Clin Lab Anal 2000; 14: 13-6.
29. Ashley-Morrow R, Nollkamper J, Robinson NJ, Bishop N, Smith J. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among females in 10 diverse geographical locations. Clin Microbiol Infect 2004; 10: 530-6.
30. Gopal R, Gibbs T, Slomka MJ, Whitworth J, Carpenter LM, Vyse A, Brown DW. A monoclonal blocking EIA for herpes simplex virus type 2 antibody: validation for seroepidemiological studies in Africa. J Virol Methods 2000; 87: 71-80.
31. Hashido M, Kawana T, Matsunaga Y, Inouye S. Changes in prevalence of herpes simplex virus type 1 and 2 antibodies from 1973 to 1993 in the rural districts of Japan. Microbiol Immunol 1999; 43: 177-80.
32. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116: 197-202.
33. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and 2. Chiron HSV vaccine Study Group. N Engl J Med 1999; 342: 1432-8.
34. Austin H, Macaluso M, Nahmias A, Lee FK, Kelaghan J, Fleenor M. Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic. Sex Transm Dis 1999; 26: 329-43.
35. Roest RW, Meijden WI, Dijk G, Green J, Mulder PGH, Verjans GMGM. Prevalence and association between herpes simplex virus types 1 and 2 specific antibodies in attendees at sexually transmitted disease clinic. Int J Epidemiology 2001; 30: 580-8.
36. Wald A, Koutsky L, Ashley RL, Corey L. Genital herpes in a primary care clinic. Demographic and sexual correlates of herpes simplex type 2 infections. Sex Transm Dis 1997; 24: 149-55.
37. Kamali A, Nunn AJ, Mulder DW, van Dyck E, Dobbins JG, Whitworth JAG. Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population. Sex Transm Infect 1999; 75: 98-102.
38. Mbizvo EM, Msuya Sia E, Stray-Pedersen B, Chirenje MZ, Munjoma M, Hussain A. Association of herpes simplex virus type 2 with the human immunodeficiency virus among urban females in Zimbabwe. Int J STD & AIDS 2002; 13: 343-8.
39. Fleming DT, Wasserheit IN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75: 3-17.
40. Diaz JJ, Dodon MD, Schaerer-Uthurralt N, Simonin D, Kindbeiter K, Gazzolo L, Madjar JJ. Post-transcriptional transactivation of human retroviral envelope glycoprotein expression by herpes simplex virus Us11 protein. Nature 1996; 379: 273-7.
41. Calistri A, Parolin C, Palu G. Herpes simplex virus type 1 can either suppress or enhance human immunodeficiency virus type 1 replication in CD4-positive T-lymphocytes. J Med Virol 2003; 70: 163-70.
42. Schaker T, Ryncarz A, Goddard J, Diem K, Shaughnessy M, Corey L. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV infected men. JAMA 1998; 280: 61-6.
43. McClelland RS, Wang CC, Overhaugh J, Richardson BA, Corey L, Ashley RL, et al. Association between cervical shedding of herpes simplex virus and HIV-1. AIDS 2002; 16: 2425-30.
44. Mbopi-Keou F-X, Grésenguet G, Mayaud P, Weiss HA, Gopal R, Matta M, et al. Interactions between herpes simplex virus type 2 and HIV-1 infection in African women: opportunities for intervention. J Infect Dis 2000; 182: 1090-6.
45. Wilson TE, Uusküla A, Feldman J, Holman S, Dehovitz J. A case-control study of beliefs and behaviours associated with sexually transmitted disease occurrence in Estonia. Sex Transm Dis 2001; 28: 624-9.
46. Stanberry LR, Spruance SL, Cunningham AL, Bernstein DI, Mindel A, Sacks S, et al. GlaxoSmithKline Herpes Vaccine Efficacy Study Group. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347: 1652-61.
47. Cowan FM, Copas A, Johnson AM, Ashley R, Corey L, Mindel A. Herpes simplex virus type 1 infection: a sexually transmitted infection of adolescence? Sex Transm Infect 2002; 78: 346-8.
48. Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003; 30: 797-800.